Skip to main content
Premium Trial:

Request an Annual Quote

DeCode Posts 35-Percent Rise in Q3 Revenue as Net Losses More Than Double

NEW YORK (GenomeWeb News) — DeCode Genetics today said third-quarter revenues decreased 35 percent as R&D spending rose 29 percent and loss increased 108 percent.
Total receipts for the three months ended Sept. 30 decreased to $8.6 million from $13.2 million year over year. Decode blamed the decline on lower alliance revenues in 2006, and because $11.8 million in revenue was deferred to future reporting periods.
R&D spending increased to $14.2 million from $11 million year over year. Decode said steady increases in R&D throughout the year are from drug discovery, clinical trials, and SNP analysis covering several disease areas.  
The company said loss increased to $23.6 million from $11.3 million in the year-ago period. The losses came from increased spending on research and in a shift in accounting standards regarding DeCode’s share-based compensation.
DeCode said it had around $126.8 million in cash and investments as of Sept. 30.
DeCode also said that a lawsuit it filed against five former employees and the Children’s Hospital of Philadelphia in September for allegedly stealing trade secrets to set up a competing lab is expected to resume this month.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.